Literature DB >> 19714489

The correlation between a family history of colorectal cancer and survival of patients with colorectal cancer.

Helgi Birgisson1, Arezo Ghanipour, Kennet Smedh, Lars Påhlman, Bengt Glimelius.   

Abstract

The purpose was to analyze survival of patients with colorectal cancer and a positive family history for colorectal cancer in first degree relatives compared with those with no such family history and to determine whether differences in survival could be explained by known clinico-pathological factors. During 2000-2003, 318 consecutive patients with colorectal cancer answered a written questionnaire about their family history for colorectal cancer. During a 6-year follow-up, recurrences and survival were registered. Thirty-one (10%) patients had a first-degree relative with colorectal cancer, moreover two patients fulfilled the criteria of hereditary non-polyposis colorectal cancer and were excluded. Patients with a first-degree relative with colorectal cancer had better survival and lower risk for recurrences compared to those with no relatives with colorectal cancer. In a multivariate analysis including age, gender, stage of disease, tumor differentiation, vascular invasion and family history, patients with first-degree relatives with colorectal cancer had lower risks for death (RR 0.37; 95% CI 0.17-0.78) and death from cancer (RR 0.25; 95% CI 0.08-0.80), compared to those with a no relative with colorectal cancer. The differences were seen in patients with colon cancer but not rectal cancer. Family history for colorectal cancer in a first-degree relative is an individual prognostic factor in patients with colon cancer and could not be explained by known clinico-pathological factors. The value of family history taking in patients with colon cancer is therefore not only to identify families with hereditary colorectal cancer, but also to add information to the prognosis of the patients.

Entities:  

Mesh:

Year:  2009        PMID: 19714489     DOI: 10.1007/s10689-009-9286-0

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  33 in total

1.  Guidance on large bowel surveillance for people with two first degree relatives with colorectal cancer or one first degree relative diagnosed with colorectal cancer under 45 years.

Authors:  M G Dunlop
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

2.  Microsatellite instability: impact on cancer progression in proximal and distal colorectal cancers.

Authors:  P Jernvall; M J Mäkinen; T J Karttunen; J Mäkelä; P Vihko
Journal:  Eur J Cancer       Date:  1999-02       Impact factor: 9.162

3.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

4.  Improved survival in cancer of the colon and rectum in Sweden.

Authors:  H Birgisson; M Talbäck; U Gunnarsson; L Påhlman; B Glimelius
Journal:  Eur J Surg Oncol       Date:  2005-10       Impact factor: 4.424

Review 5.  Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

Authors:  C C Compton; L P Fielding; L J Burgart; B Conley; H S Cooper; S R Hamilton; M E Hammond; D E Henson; R V Hutter; R B Nagle; M L Nielsen; D J Sargent; C R Taylor; M Welton; C Willett
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

6.  A prospective study of family history and the risk of colorectal cancer.

Authors:  C S Fuchs; E L Giovannucci; G A Colditz; D J Hunter; F E Speizer; W C Willett
Journal:  N Engl J Med       Date:  1994-12-22       Impact factor: 91.245

7.  Impact of family history of colon cancer on development of multiple primaries after diagnosis of colon cancer.

Authors:  M L Slattery; M Mori; R Gao; R A Kerber
Journal:  Dis Colon Rectum       Date:  1995-10       Impact factor: 4.585

8.  Association of family history with cancer recurrence and survival among patients with stage III colon cancer.

Authors:  Jennifer A Chan; Jeffrey A Meyerhardt; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; James Thomas; Paul Schaefer; Renaud Whittom; Alexander Hantel; Richard M Goldberg; Robert S Warren; Monica Bertagnolli; Charles S Fuchs
Journal:  JAMA       Date:  2008-06-04       Impact factor: 56.272

9.  Clinical and pathological analyses of patients with a family history of colorectal cancer. Registry Committee, Japanese Research Society for Cancer of the Colon and Rectum.

Authors: 
Journal:  Jpn J Clin Oncol       Date:  1993-12       Impact factor: 3.019

10.  The effect of family history of cancer, religion, parity and migrant status on survival in colorectal cancer. The Melbourne Colorectal Cancer Study.

Authors:  G A Kune; S Kune; L F Watson
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

View more
  12 in total

1.  The impact of stratifying by family history in colorectal cancer screening programs.

Authors:  Simon Lucas Goede; Linda Rabeneck; Iris Lansdorp-Vogelaar; Ann G Zauber; Lawrence F Paszat; Jeffrey S Hoch; Jean H E Yong; Frank van Hees; Jill Tinmouth; Marjolein van Ballegooijen
Journal:  Int J Cancer       Date:  2015-02-20       Impact factor: 7.396

2.  Survival in familial colorectal cancer: a Danish cohort study.

Authors:  Charlotte Kvist Lautrup; Ellen M Mikkelsen; Timothy L Lash; Niels Katballe; Lone Sunde
Journal:  Fam Cancer       Date:  2015-12       Impact factor: 2.375

3.  The impact of positive cancer family history on the clinical features and outcome of patients with non-small cell lung cancer.

Authors:  Ning Li; Kang Shao; Zhaoli Chen; Bin Qiu; Zhen Wang; Fengwei Tan; Jiwen Wang; Xiaogang Tan; Baozhong Li; Meihua Xiong; Fang Zhou; Jie He
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

4.  Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas.

Authors:  Tilman Laubert; Jens K Habermann; Claudia Hemmelmann; Markus Kleemann; Elisabeth Oevermann; Ralf Bouchard; Philipp Hildebrand; Thomas Jungbluth; Conny Bürk; Hamed Esnaashari; Erik Schlöricke; Martin Hoffmann; Andreas Ziegler; Hans-Peter Bruch; Uwe J Roblick
Journal:  BMC Gastroenterol       Date:  2012-03-23       Impact factor: 3.067

5.  Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes.

Authors:  Kari Hemminki; Irene Santi; Marianne Weires; Hauke Thomsen; Jan Sundquist; Justo Lorenzo Bermejo
Journal:  BMC Cancer       Date:  2010-12-21       Impact factor: 4.430

6.  Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival.

Authors:  Helgi Birgisson; Ulrik Wallin; Lars Holmberg; Bengt Glimelius
Journal:  BMC Cancer       Date:  2011-10-11       Impact factor: 4.430

7.  A retrospective observational study of the relationship between single nucleotide polymorphisms associated with the risk of developing colorectal cancer and survival.

Authors:  Eva J A Morris; Steve Penegar; Nicola Whiffin; Peter Broderick; D Timothy Bishop; Emma Northwood; Philip Quirke; Paul Finan; Richard S Houlston
Journal:  PLoS One       Date:  2015-02-24       Impact factor: 3.240

8.  A retrospective observational study of the relationship between family history and survival from colorectal cancer.

Authors:  E J A Morris; S Penegar; L E Whitehouse; P Quirke; P Finan; D T Bishop; J Wilkinson; R S Houlston
Journal:  Br J Cancer       Date:  2013-03-19       Impact factor: 7.640

9.  Association Between Health Behaviors and Family History of Cancer in Cancer Survivors: Data From the Korean Genome and Epidemiology Study.

Authors:  Minji Hwang; Boyoung Park
Journal:  J Cancer Prev       Date:  2017-09-30

10.  Association of family history and survival in patients with colorectal cancer: a pooled analysis of eight epidemiologic studies.

Authors:  Dawn Q Chong; Barbara L Banbury; Amanda I Phipps; Xinwei Hua; Jonathan Kocarnik; Ulrike Peters; Sonja I Berndt; Wen-Yi Huang; John D Potter; Martha L Slattery; Emily White; Peter T Campbell; Tabitha Harrison; Polly A Newcomb; Andrew T Chan
Journal:  Cancer Med       Date:  2018-03-26       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.